OTS 2019 Speakers
Eric Bernabei
Chief Sales & Marketing Officer, Avellino Labs
Tom Burns
CEO, Glaukos
Bill Carpou
CEO, OCTANe
Andy Corley
Partner, Flying L Partners & Principal, YELROC Consulting
Jag Dosanjh
Senior VP, Specialty Therapeutics Eyecare, Botox Therapeutics, Allergan
David Endicott
CEO, Alcon
Tom Frinzi
World Wide President, Surgical, Johnson & Johnson
Bruce Feuchter
Senior Shareholder, Stradling
A.J Ghergich
Chief Technology Officer Digital Intelligence, Brado Creative Insights
Kamran Hosseini, MD, PhD
President & CEO, Surface Pharmaceuticals
John Hovanesian, MD, FACS
Private Practice, Harvard Eye Associates, Laguna Hills, CA Clinical Faculty, UCLA Jules Stein Eye Institute, Los Angeles, CA
Elad Kedar
CEO, Orasis Pharmaceuticals
Curt Labelle, MD, MBA
Director, Eyenovia
Richard Lindstrom, MD
Founder & Attending Surgeon, Minnesota Eye Consultants
William Link, Ph.D
Managing Partner, Flying L Partners & Managing Director, Versant Ventures
Jennifer Loh, MD
Loh Ophthalmology Associates
Bradford Manning
Co-Founder, Two Blind Brothers
Bryan Manning
Co-Founder, Two Blind Brothers
Caren Mason
President & CEO, STAAR Surgical
Cynthia Matossian, MD
Matossian Eye
Jim Mazzo
Global President of Ophthalmic Devices, ZEISS
Jason Menzo
Chief Operating Officer, Foundation Fighting Blindness
Tom Mitro
President & COO, Aerie Pharmaceuticals
Monty Montoya
President and CEO, CorneaGen
Raqiyyah R. Pippins, JD
Partner, Arnold & Palmer
David Pyott
Former CEO, Allergan
Ramgopal Rao
CEO, LensGen
Sheri Rowen, MD
NVISION Eye Center
JC Ruffalo
Director, LaunchPad SBDC, OCTANe
Ehsan Sadri, MD, FACS
Founding Member, Visionary Venture Fund
John Sheets, PhD
President, Elisar Health
Richard Small
President, Neurotech
Paul Stubenbordt
President Stubenbordt Consulting
Robert Thornhill
CEO, Tearfilm Innovations, A Divison of Alcon
Farrell "Toby" Tyson, MD
Tyson Eye
Jeffrey Weinhuff
Managing Partner, Visionary Venture Fund
Elizabeth Yeu, MD
Partner, Virginia Eye Consultants
© 2020 Octane